<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04067271</url>
  </required_header>
  <id_info>
    <org_study_id>19-019</org_study_id>
    <nct_id>NCT04067271</nct_id>
  </id_info>
  <brief_title>LUEbeck Registry of Intensive Care Patients - Characterization of the Patients Intestinal MICROBIOME</brief_title>
  <acronym>LUERIC-M</acronym>
  <official_title>LUEbeck Registry of Intensive Care Patients - Characterization of the Patients Intestinal MICROBIOME</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Luebeck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Luebeck</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the current study is to analyze the effects of ICU-care on changes in
      microbiome and the influence of intestinal microbiome changes on short-term and long-term
      morbidity and mortality of ICU patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 18, 2019</start_date>
  <completion_date type="Anticipated">March 18, 2024</completion_date>
  <primary_completion_date type="Anticipated">March 18, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Modification of the microbiome</measure>
    <time_frame>Day 0</time_frame>
    <description>The modification of the microbiome using ribosomal 16 S DNA sequencing and clustering for Operational Taxonomic Units (OTU) and calculated Shannon Index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU intensive care unit stay</measure>
    <time_frame>Day 0</time_frame>
    <description>Duration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>Month 12</time_frame>
    <description>Duration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>Month 6</time_frame>
    <description>Duration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>Month 6</time_frame>
    <description>To discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>Month 12</time_frame>
    <description>To discharge</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>ICU Patients</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Analyze changes in intestinal microbiome</intervention_name>
    <description>Descriptive Analysis</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who receive treatment on ICU.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥18 years

          -  All patients receiving intensive medical care

          -  A written informed consent from the patient or two independent doctors or legal
             guardians.

        Exclusion Criteria:

          -  Age &lt;18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tobias Graf, MD</last_name>
    <phone>+49 451 500 75306</phone>
    <email>tobias.graf@uksh.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roza Meyer-Saraei, PhD</last_name>
    <phone>+49 451 500 44542</phone>
    <email>roza.meyer-saraei@uksh.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical Clinic II-UKSH Campus Lübeck</name>
      <address>
        <city>Luebeck</city>
        <state>Schleswig-Holstein</state>
        <zip>23562</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Graf, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 21, 2019</study_first_submitted>
  <study_first_submitted_qc>August 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 26, 2019</study_first_posted>
  <last_update_submitted>August 23, 2019</last_update_submitted>
  <last_update_submitted_qc>August 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Luebeck</investigator_affiliation>
    <investigator_full_name>Dr. med. Tobias Graf</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

